PRRT2 and neoplasm: PKC signalling and oncogenic signalling converge and contribute to the transformed phenotype [102,103,104], however it remains unclear as to whether tumour promotion is a result of changes in specific activity, or by changes in the expression of the protein [33,105,106,107,108].